<?xml version="1.0" encoding="UTF-8"?>
<p id="Par48">Allogenic cells are highly immunogenic and are rejected even by immunocompromised hosts [
 <xref ref-type="bibr" rid="CR39">39</xref>]. The rejection of the mis-matched cells eliminates risk of GVHD side-effects of allogeneic cell administration. Multiple ID injections of AlloStim
 <sup>®</sup> amplify the titer of allo-specific Th1/CTL cells in circulation and a portion of these cells differentiate into long lasting memory cells. These allo-specific Th1/CTL memory cells provide a functional pool of immune cells that are capable of non-specific (by-stander) activation [
 <xref ref-type="bibr" rid="CR40">40</xref>] upon encounter with virus [
 <xref ref-type="bibr" rid="CR14">14</xref>, 
 <xref ref-type="bibr" rid="CR41">41</xref>] resulting in immediate release of IFN-ϒ.
</p>
